Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study

被引：0
|
作者：
Caterina Motta
Martina Gaia Di Donna
Chiara Giuseppina Bonomi
Martina Assogna
Agostino Chiaravalloti
Nicola Biagio Mercuri
Giacomo Koch
Alessandro Martorana
机构：
[1] UOSD Centro Demenze,Experimental Neuropsychophysiology Laboratory
[2] University of Rome “Tor Vergata”,Department of Biomedicine and Prevention
[3] IRCCS Santa Lucia Foundation,Human Physiology Unit, Department of Neuroscience and Rehabilitation
[4] University of Rome Tor Vergata,undefined
[5] Istituto Neurologico Mediterraneo,undefined
[6] University of Ferrara,undefined
来源：
Alzheimer's Research & Therapy | / 15卷
关键词：
Alzheimer’s disease; Cerebrospinal fluid biomarkers; Amyloid beta 40; Amyloid beta 42; Amyloid beta 42/40 ratio; Phosphorylated-tau; Fluorodeoxyglucose-positron emission tomography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association between Hypocretin-1 and Amyloid-β42 Cerebrospinal Fluid Levels in Alzheimer's Disease and Healthy Controls
    Slats, Diane
    Claassen, Jurgen A. H. R.
    Lammers, Gert Jan
    Melis, Rene J.
    Verbeek, Marcel M.
    Overeem, Sebastiaan
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (10) : 1119 - 1125
  • [32] Interactions between Amyloid-β and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease
    Kristofikova, Zdena
    Ricny, Jan
    Kolarova, Michaela
    Vyhnalek, Martin
    Hort, Jakub
    Laczo, Jan
    Sirova, Jana
    Ripova, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S91 - S98
  • [33] Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer's Disease
    Ahmad, Syed Sayeed
    Khan, Haroon
    Rizvi, Syed Mohd. Danish
    Ansari, Siddique Akber
    Ullah, Riaz
    Rastrelli, Luca
    Mahmood, Hafiz Majid
    Siddiqui, Mohd. Haris
    MOLECULES, 2019, 24 (18):
  • [34] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Katherine W. Turk
    Alexandra Geada
    Victor E. Alvarez
    Weiming Xia
    Jonathan D. Cherry
    Raymond Nicks
    Gaoyuan Meng
    Sarah Daley
    Yorghos Tripodis
    Bertrand R. Huber
    Andrew E. Budson
    Brigid Dwyer
    Neil W. Kowall
    Robert C. Cantu
    Lee E. Goldstein
    Douglas I. Katz
    Robert A. Stern
    Michael L. Alosco
    Jesse Mez
    Ann C. McKee
    Thor D. Stein
    Alzheimer's Research & Therapy, 14
  • [35] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Turk, Katherine W.
    Geada, Alexandra
    Alvarez, Victor E.
    Xia, Weiming
    Cherry, Jonathan D.
    Nicks, Raymond
    Meng, Gaoyuan
    Daley, Sarah
    Tripodis, Yorghos
    Huber, Bertrand R.
    Budson, Andrew E.
    Dwyer, Brigid
    Kowall, Neil W.
    Cantu, Robert C.
    Goldstein, Lee E.
    Katz, Douglas I.
    Stern, Robert A.
    Alosco, Michael L.
    Mez, Jesse
    McKee, Ann C.
    Stein, Thor D.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [36] Association between amyloid-β42 levels and neuropsychiatric symptoms in Alzheimer's disease trials
    Abanto, Jesus Thomas
    Dwivedi, Alok K.
    Imbimbo, Bruno P.
    Espay, Alberto J.
    BRAIN COMMUNICATIONS, 2025, 7 (02)
  • [37] Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
    Cullen, Nicholas C.
    Janelidze, Shorena
    Stomrud, Erik
    Bateman, Randall J.
    Palmqvist, Sebastian
    Hansson, Oskar
    Mattsson-Carlgren, Niklas
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [38] Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-β38/40/42 in Frontotemporal Dementias and Primary Progressive Aphasias
    Bibl, Mirko
    Mollenhauer, Brit
    Lewczuk, Piotr
    Esselmann, Hermann
    Wolf, Stefanie
    Otto, Markus
    Kornhuber, Johannes
    Ruether, Eckart
    Wiltfang, Jens
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (01) : 37 - 44
  • [39] Cerebrospinal Fluid Soluble Amyloid-β Protein Precursor as a Potential Novel Biomarkers of Alzheimer's Disease
    Lewczuk, Piotr
    Popp, Julius
    Lelental, Natalia
    Koelsch, Heike
    Maier, Wolfgang
    Kornhuber, Johannes
    Jessen, Frank
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 28 (01) : 119 - 125
  • [40] Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endotheliums
    Sharda, Nidhi
    Ahlschwede, Kristen M.
    Curran, Geoffry L.
    Lowe, Val J.
    Kandimalla, Karunya K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 376 (03): : 482 - 490
12345